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           Most interstitial tissues contain populations of 
resident DC and macrophages. In conventional 
descriptions, there is a division of labor between 
DC, which are dedicated to the induction and 
control of adaptive immunity (  1, 2  ), and macro-
phages, which are occupied with the clearance of 
senescent cells, extracellular debris, and mainte-
nance of tissue homeostasis (  3, 4  ). According to 
mouse models, functional specialization is mir-
rored by diff  erences in rates of turnover; DC 
transit rapidly through the tissues ( 5  –  7  ), whereas 
macrophages are predominantly   “  fi  xed  ”   cells (  8  ). 
  Recent studies of the human dermis have 
emphasized the apparent phenotypic diff  erences 
between resident DC and macrophages (  9, 10  ), 
whereas others have argued that conversion be-
tween macrophage and DC phenotypes might 
occur according to conditions of quiescence or 
infl  ammation (  11  –  13  ). Many investigators have 
focused on migratory dermal DC that are more 
easily obtained in an enriched form and have 
value as a model of maturing DC (  11, 14  –  20  ). 
Rather less progress has been made in charac-
terizing human dermal DC and macrophages in 
a freshly isolated state (  9, 10, 21, 22  ), and the 
relationship between migrant and resident APC 
populations remains unclear. 
  Hematopoietic stem cell transplantation 
is a powerful means of defi  ning the ontogeny of 
BM-derived cells and has been previously used 
in humans to prove the BM origin of Langerhans 
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  Animal models of hematopoietic stem cell transplantation have been used to analyze the 
turnover of bone marrow  –  derived cells and to demonstrate the critical role of recipient 
antigen-presenting cells (APC) in graft versus host disease (GVHD). In humans, the phe-
notype and lineage relationships of myeloid-derived tissue APC remain incompletely 
understood. It has also been proposed that the risk of acute GVHD, which extends over 
many months, is related to the protracted survival of certain recipient APC. Human 
dermis contains three principal subsets of CD45  +  HLA-DR  +   cells: CD1a  +  CD14        DC, 
CD1a       CD14  +   DC, and CD1a       CD14  +  FXIIIa  +   macrophages. In vitro, each subset has charac-
teristic properties. After transplantation, both CD1a  +   and CD14  +   DC are rapidly depleted 
and replaced by donor cells, but recipient macrophages can be found in GVHD lesions and 
may persist for many months. Macrophages isolated from normal dermis secrete proin-
fl  ammatory cytokines. Although they stimulate little proliferation of naive or memory 
CD4  +   T cells, macrophages induce cytokine expression in memory CD4  +   T cells and activa-
tion and proliferation of CD8  +   T cells. These observations suggest that dermal macro-
phages and DC are from distinct lineages and that persistent recipient macrophages, 
although unlikely to initiate alloreactivity, may contribute to GVHD by sustaining the 
responses of previously activated T cells. 
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    Figure 1.         Characterization of resident dermal APC.   (A) Strategy used in the characterization of resident CD45  + HLA-DR +   dermal cells showing suc-
cessive gating on DAPI-live cells, CD45  +   cells, and HLA-DR  +   cells. Progressive refi  nement of SSC  lo AF lo   and  SSC hi AF hi   fractions is depicted at each step by 
the corresponding panel below. CD45  +   cells include macrophages, DC, mast cells, and lymphocytes. Mast cells (high SSC) are HLA-DR       , as are the majority 
of lymphocytes (low SSC), and are easily excluded by the fi  nal HLA-DR gate. AF was recorded in the FL1 channel (488-nm laser and 530/30 band-pass 
fi  lter). Similar results were found in   >  50 independent preparations of skin. (B) Further analysis of SSC  lo AF lo   and  SSC hi AF hi   fractions of CD45  + HLA-DR +   cells 
by expression of CD14  +   and  CD1a +  . Blue indicates the position of isotype controls and red the expression of CD14/CD1a by each fraction. Three principal 
populations were sorted and show distinct morphological appearances by Giemsa staining (right). Bar, 20   μ  m. A representative example of three experi-
ments is shown. (C) Surface phenotype of resident CD45  + HLA-DR +   dermal cells. Gates were placed as described in A and B using CD45, HLA-DR, SSC, AF JEM VOL. 206, February 16, 2009 
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CD1a, and CD14 to defi  ne macrophages (mac), CD14  +   DC, and CD1a  +   DC. CD14 expression on DC cells was analyzed by gating on CD1a  +   and  CD1a       cells. 
All other markers for CD1a  +   DC and CD14  +   DC were determined by gating on CD14        and  CD14 +   populations, respectively. Staining was performed at least 
six times on different skin preparations with similar results. (D) Identifi  cation of large melanosome-laden macrophages by CD45, HLA-DR, and FXIIIa. 
Freshly isolated APC prepared on cytospin were simultaneously stained with antibodies to CD45 (green), HLA-DR (red), and FXIIIa (blue). After immuno-
fl  uoresence imaging the coverslip was removed and the slide stained with Giemsa. FXIIIa staining is restricted to macrophages that are a subset of the 
HLA-DR+ APC in the preparation (red). A number of small agranular HLA-DR+ DC with reniform nuclei are FXIIIa negative. All HLA-DR  +   cells and a num-
ber of small lymphocytes in the fi  eld are highlighted by CD45 staining. Bar, 20   μ  m. This fi  nding was reproduced three times.     
 
cells (LC) (  23  ), alveolar macrophages (  24  ), and Kupff  er cells 
(  25  ). However, the lineage relationships of macrophages and 
DC are unknown because it has not been possible to analyze 
their turnover in the same organ with suffi   cient resolution. 
Understanding the ontogeny of BM-derived APC has many 
clinical implications. Tandem transplant experiments in mice 
have shown that competent recipient APC are required for 
the induction of acute graft versus host disease (GVHD) (  26  ). 
It has generally been assumed, without rigorous proof, that 
DC are the predominant APC responsible for stimulating do-
nor T cells (for review see references   27  ;   28  ). Specifi  c recipient 
DC populations such as LC are indeed suffi   cient to induce 
GVHD (  29  ), but other experimental systems show that mac-
rophages may also play a role (  30  ). According to current mod-
els, macrophage involvement in GVHD has principally been 
described in terms of their innate immune function, such as 
the production of TNF-     in response to IFN-     and LPS 
(  31, 32  ), rather than through antigen-specifi  c T cell stimulation. 
  The search for persistent recipient APC in humans has been 
further promoted by a wealth of clinical data indicating that 
the risk of acute GVHD after immunosuppression withdrawal 
or donor lymphocyte infusion (DLI) remains signifi  cant for up 
to 12 mo after transplantation (  33  –  38  ). It is known that recipient 
LC persist after donor hematopoietic stem cell engraftment, es-
pecially after reduced intensity conditioning, and that donor LC 
engraftment is stimulated by GVHD (  39, 40  ). However, very 
few recipient LC persist after 3 mo (  40, 41  ), indicating the po-
tential involvement of other APC in promoting GVHD. Der-
mal APC are indirectly implicated in the pathogenesis of GVHD 
by many histopathological studies (  42  –  46  ). We have also previ-
ously described recipient HLA-DR  +   cells in dermis for at least 
1 mo after transplantation in the absence of GVHD (  47, 48  ). 
  In this study, we have investigated resident dermal DC 
and macrophages in human skin. We characterize their phe-
notypes and function in vitro, determine their kinetics of turn-
over during transplantation, and investigate their potential to 
stimulate allogeneic T cells through cytokine production and 
antigen-specifi  c interactions. Our observations suggest that 
dermal macrophages outlive all other cutaneous APC and may 
have the capacity to promote GVHD through both innate 
infl  ammatory properties and antigen-specifi  c stimulation of 
allogeneic T cell responses. 
    RESULTS   
  Human dermal APC defi  ned 
  Upon 6  –  12-h collagenase digestion of freshly keratomed der-
mis, several populations of DAPI-negative cells are evident 
from analysis of autofl  uorescence (AF) and side scatter (SSC) 
alone (  Fig. 1 A  ).   These may be refi  ned by successively gat-
ing on CD45  +   cells, which includes DC, macrophages, 
mast cells, and lymphocytes, and then on HLA-DR  +   cells, 
which excludes mast cells and lymphocytes, to produce two 
major fractions separable by SSC and AF: SSC  lo  AF  lo   and SS-
C  hi  AF  hi  . The SSC  hi  AF  hi   fraction is especially fl  uorescent in 
channels excited by the 488-nm laser. In the experiments 
shown, AF was recorded in FL1. 
  CD45  +  HLA-DR  +  SSC  hi  AF  hi   cells comprise a striking popu-
lation characterized by intracytoplasmic melanosomes (  Fig. 1 B  ). 
Their appearance contrasts markedly with CD45  +  HLA-
DR  +  SSC  lo  AF  lo   cells, which further analysis shows to contain 
the classical human dermal DC populations characterized by 
diff  erential CD14 and CD1a expression (  11, 14  –  20  ) (  Fig. 1 B  ). 
Note that plotting CD14 versus CD1a directly from gated 
CD45  +  HLA-DR  +   dermal cells results in overlap of the CD14  +   
cell and the macrophage, which is highly autofl  uorescent but 
also expresses a low level of CD14 (  Fig. 1 B  ). 
  There are consistent morphological diff  erences between 
SSC  lo  AF  lo   CD1a  +  CD14        and CD14  +  CD1a        subpopulations 
(  Fig. 1 B  ). As shown in   Figs. 1 and 2  , CD14  +   DC display 
several intermediate phenotypic and functional properties of 
CD1a  +   DC and macrophages.   We found no evidence to in-
dicate that circulating monocytes contribute signifi  cantly to 
the CD14  +   DC population. In particular, B cells, which are 
present at an     1:1 ratio with monocytes in blood, are equiv-
alent to only 2  –  5% of the number of CD14  +   cells present 
(unpublished data). In addition, monocytes have much higher 
CD52 and do not up-regulate HLA-DR to the same level 
after overnight exposure to medium from a dermal digest 
preparation (unpublished data). 
  The surface phenotype of each population was defi  ned 
using the strategy outlined in   Fig. 1 (A and B)   to identify 
CD1a  +   DC, CD14  +   DC, and macrophages (  Fig. 1 C  ). CD1a  +   
DC are uniformly CD1c high but usually do not express 
CD163. CD14  +   DC show variable CD1a and CD1c expres-
sion in addition to CD163. Macrophages show consistent 
CD163 and CD14 expression but lack CD1a or CD1c. Ex-
pression of CD45 and HLA-DR is lower on macrophages as 
determined by the change in mean fl  uorescence intensity or 
by mean fl  uorescence intensity ratio, but because of higher 
background AF the absolute brightness of HLA-DR staining 
always appears equivalent to the DC populations. Measure-
ment of lectin expression was hampered by sensitivity to col-
lagenase and is not depicted. Costimulatory molecules CD80 
and CD86 are expressed predominantly by CD1a  +   DC and at 374 DERMAL DC AND MACROPHAGES IN TRANSPLANTATION   | Haniffa et al. 
  Dermal macrophages, but not DC, survive conditioning 
  As a fi  rst step to defi  ning the turnover of dermal APC during 
transplantation, we investigated their ability to survive condi-
tioning therapy, the preparative regimen of cytoreductive 
drugs and total body irradiation which is given to patients 
before they receive allogeneic cells. Conditioning therapy 
depletes the blood of leukocytes but the eff  ect on interstitial 
APC, such as dermal DC and macrophages, has not been previ-
ously studied. 
  We obtained pre- and postconditioning skin shave biopsies 
from patients scheduled for hematopoietic stem cell trans-
plantation. Postconditioning biopsies were taken on day 0. 
Dermal DC and macrophages per unit area were measured 
by freshly digesting a standard area of dermis and counting 
the total number of cells by fl  ow cytometry. We used a simi-
lar gating strategy to that defi  ned in   Fig. 1   to count CD1a  +   
DC, CD14  +   DC, and macrophages (  Fig. 3 A  ).   This reveals 
rapid and selective depletion of CD1a  +   DC but preserva-
tion of macrophages and CD14  +   DC (  Fig. 3 B  ). Selective 
depletion of CD1a  +   DC is observed in patients receiving 
both reduced intensity conditioning, which does not com-
pletely ablate the hematopoietic stem cell compartment, and 
full intensity or myeloablative conditioning (  Fig. 3 C  ; and 
see Table S1 [available at http://www.jem.org/cgi/content/
full/jem.20081633/DC1] for further clinical details). CD14  +   
DC appear to increase slightly after full intensity condition-
ing, possibly refl  ecting some recruitment caused by cytotoxic 
injury. The preservation of dermal macrophages is also seen 
directly with immunofl  uorescence staining, using CD163 as 
an alternative marker to FXIIIa (  Fig. 3 D  ). Because alemtu-
zumab (humanized anti-CD52 antibody) was a component 
of the conditioning regimen in this cohort of patients, we 
also determined the level of CD52 expression by diff  erent APC 
populations. As shown in   Fig. 3 E  , the expression of CD52 is 
much lower on dermal APC compared with dermal T cells, 
which are similar to peripheral blood T cells (not depicted). 
Although CD1a  +   DC have slightly higher CD52 levels than 
CD14  +   DC and macrophages, it appears unlikely that direct 
cytotoxicity by alemtuzumab is a major cause of diff  erential 
depletion of DC in this cohort of patients. 
  Differential replacement of dermal DC and macrophages 
during transplantation 
  Diff  erential rates of replacement of BM-derived cells suggest 
the existence of distinct lineages. In addition, the persistence of 
recipient APC capable of stimulating donor T cells is thought 
to be a critical factor in promoting GVHD. To examine these 
questions, we measured the repopulation of each APC com-
partment by donor cells. Dermal APC were prepared from 
shave biopsies of patients receiving hematopoietic stem cell 
grafts from sex-mismatched donors. Chimerism was analyzed 
by sequential immunofl  uorescence and fl  uorescence in situ 
hybridization (FISH) with X/Y probes. A combination of anti-
bodies to HLA-DR, CD14, and FXIIIa was selected in order 
to defi  ne the same three populations of CD1a  +   DC, CD14  +   
DC, and macrophages that had been previously characterized. 
a lower level on CD14  +   DC; macrophages usually express 
only a low level of CD86. CD83 expression is largely re-
stricted to CD1a  +   DC. The integrin CD11c, but not CD11b, 
is DC restricted as in the mouse. The intracellular antigen 
factor XIIIa (FXIIIa) is expressed at much higher levels by in 
vitro  –  digested macrophages than either DC (change in mean 
fl  uorescence intensity of 17,448 units above control com-
pared with 2,181 units). On cytospin preparations, FXIIIa 
specifi  cally identifi  es macrophages, marking a subset of large 
HLA-DR  +   cells that contain melanosomes when the section 
is subsequently stained with Giemsa. Many other HLA-DR  +   
DC in the same fi  eld are not highlighted by FXIIIa staining 
(  Fig. 1 D  ). It has previously been reported that FXIIIa identi-
fi  es macrophages in situ (  9  ). We also found that this antigen 
marked a subset of HLA-DR  +   cells in situ that contain mela-
nosomes when the section is subsequently lightly stained with 
hematoxylin and eosin (Fig. S1 A, available at http://www
.jem.org/cgi/content/full/jem.20081633/DC1). Gene expres-
sion studies also confi  rm that much higher levels of FXIIIa 
messenger RNA are found in macrophages than in either 
of the DC subsets (Fig. S1 B). We therefore conclude that 
FXIIIa is an appropriate marker to identify macrophages 
for the purpose of microscopy, even though low level 
FXIIIa expression may be detectable in DC populations by 
fl  ow cytometry. 
  In summary, the dermal macrophage may be defi  ned 
as CD45  +  HLA-DR  +  SSC  hi  AF  hi  CD14  +  CD1a       FXIIIa  +  . Two 
subsets of dermal DC are found in the CD45  +  HLA-
DR  +  SSC  lo  AF  lo   fraction that may be further divided by CD1a 
and CD14 expression. In the studies that follow, we use 
CD45, HLA-DR, SSC, AF, and CD14/CD1a for fl  ow cyto-
metry and HLA-DR, CD14, and FXIIIa for microscopy. 
As shown by others, CD163 may also substitute for FXIIIa in 
in situ studies of macrophages and, similar to FXIIIa, this is 
also detectable at low levels on CD14  +   DC by fl  ow cytome-
try (  9, 20  ). 
  Functional properties of human dermal APC 
  Having defi  ned three principal populations of dermal APC by 
surface phenotype, we compared the in vitro properties that 
conventionally separate DC from macrophages. After 72 h in 
culture, CD1a  +   and CD14  +   dermal DC migrate easily from 
dermal sheets, but the macrophages remain fi  xed (  Fig. 2 A  ) 
and can only be recovered from the digested dermal   “  rem-
nant.  ”   Freshly isolated CD1a  +   DC have uniform CCR7 ex-
pression but macrophages remain negative and CD14  +   DC are 
variable (  Fig. 2 A  ). We attempted to induce migration of mac-
rophages using a variety of infl  ammatory mediators, including 
GM-CSF, LPS, TNF-    , and IFN-    , but none of these stimuli 
induced them to leave the dermis or up-regulate expression 
of CCR7 (unpublished data). Diff  erences in phagocytosis of 
FITC dextran (  Fig. 2 B  ) and adherence to tissue culture plastic 
(  Fig. 2 C  ) are also evident. These results are consistent with the 
classical view that DC are nonadherent cells with lower phago-
cytic activity than highly adherent macrophages. When freshly 
isolated, CD14  +   DC show intermediate behavior. JEM VOL. 206, February 16, 2009 
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    Figure 2.         Functional properties of dermal myeloid cells.   (A) Differential migration of dermal myeloid cells. 1-cm square dermal sheets were freshly digested 
with collagenase or incubated in RPMI 10% FCS for 72 h in low adhesive culture plates, after which migrant cells were collected and the remnant dermis was 
digested to release nonmigrating cells. CD45  + HLA-DR +   gated cells were analyzed by SSC and AF and further separated into CD14  +/      fractions as described in 
 Fig.  1 .  Populations a  –  e were sorted by fl  ow cytometry for morphological analysis as shown. CCR7 expression was determined on freshly isolated populations. The 
experiment was repeated 12 times with similar fi  ndings. Bar, 20   μ  m. (B) Phagocytosis of FITC dextran by dermal myeloid cells. 5   ×   10  5   collagenase-digested  dermal 
cells were incubated with 1 mg/ml of FITC-coated dextran particles at 37 or 4  °  C for 1 h in RPMI containing 10% FCS. Cells were harvested and washed before 
immunostaining. Fluorescence histograms show a representative example. For the bar charts, all three are independent experiments.     MFI, change in geometric 
mean fl  uorescence compared with no dextran control. (C) Adherence of dermal myeloid cells. 5   ×   10  5   collagenase-digested cell suspensions were cultured over-
night in RPMI containing 10% FCS. Nonadherent cells and washes were collected and pooled. Adherent cells were removed by trypsinization. Flow cytometric 
analysis was performed using SSC, AF, CD14, and CD1a according to   Fig. 1  . A representative example is shown with the cumulative results of fi  ve independent 
experiments. Bars represent the means.    376 DERMAL DC AND MACROPHAGES IN TRANSPLANTATION   | Haniffa et al. 
as HLA-DR  +  CD14  +  FXIIIa       , and macrophages as HLA-
DR  +  CD14  +  FXIIIa  +  . Although there was some low-level 
induction of FXIIIa on migratory CD14  +   cells, the majority 
Anti-CD3 was also added to migratory preparations to 
identify lymphocytes. In these experiments, CD1a  +   DC 
were identifi  ed as HLA-DR  +  CD14       FXIIIa       , CD14  +   DC 
    Figure 3.         Effect of conditioning therapy on recipient dermal DC and macrophages.   (A) Representative fl  ow cytometry analysis of dermal cell 
suspensions derived from clinical biopsies by collagenase digestion before and after conditioning. Selective depletion of SSC  lo AF lo CD14     CD1a +   DC is evi-
dent. (B) Paired analysis of dermal cells obtained before and after conditioning from a total of 27 patients showing a decline in CD1a  +   DC but preserva-
tion of CD14  +   DC and macrophages. Enumeration of cells per unit area was achieved using a standard 2-mm punch of shaved dermis freshly digested 
into single cell suspension with collagenase. The total number of cells present in each fraction was quantifi  ed with the aid of Trucount fl  uorescent beads. 
(C) Subgroup analysis of 17 patients treated with reduced intensity and 10 patients with full intensity conditioning showing similar depletion of dermal 
DC in both groups. P   <  0.001 for before and after counts (Wilcoxon rank sum test). There is also a slight but nonsignifi  cant increase in CD14  +   DC with full 
intensity conditioning. Error bars indicate SD. (D) Immunofl  uorescence images of skin before and after conditioning showing maintenance of CD163  +  
perivascular macrophages. AF in the green channel can be seen in some cells (arrows). Bar, 50   μ  m. Two representative examples of six patients are shown. 
(E) Expression of CD52 antigen by dermal APC (red) compared with isotype controls (blue). Numbers indicate median fl  uorescence intensity ratios. Dermal 
T cells in the same preparation are shown for comparision. Normal skin was prepared stained and gated as described in   Fig. 1  .   JEM VOL. 206, February 16, 2009 
ARTICLE
377
of strongly FXIIIa  +   cells were confi  ned to digested prepara-
tions (Fig. S2, available at http://www.jem.org/cgi/content/
full/jem.20081633/DC1). These were further confi  rmed as 
macrophages either by the observation of fl  uorescent mela-
nosomes during FISH or by a third sequential analysis with 
Giemsa staining to demonstrate intracellular melanin as de-
scribed earlier in   Fig. 1 D  . 
  A cohort of 52 patients was biopsied at intervals of 40, 100, 
and 365 d after transplantation (see Table S2 [available at http://
www.jem.org/cgi/content/full/jem.20081633/DC1] for fur-
ther clinical details). Biopsies were either digested freshly or 
split into migratory and digested remnant preparations. LC 
from epidermal sheets of the biopsies were also prepared for 
comparison.   Fig. 4 A   shows a migratory dermal preparation 
containing predominantly donor-derived CD14  +   and CD14        
DC. A single recipient FXIIIa  +   macrophage is also present.   A 
digested remnant preparation in   Fig. 4 B   contains mostly re-
cipient macrophages and some residual donor-derived CD14        
(CD1a  +  ) DC. Regardless of the mode of sample preparation, 
we consistently observed higher donor engraftment of both 
subsets of DC than macrophages (Fig. S3 and Table S3 available 
at http://www.jem.org/cgi/content/full/jem.20081633/DC1). 
The pooled data are presented in   Fig. 4 C  . This shows that re-
cipient CD14  +   and CD14        DC are nearly completely replaced 
by 40 d, which is in synchrony with peripheral blood myeloid 
engraftment, but that a proportion of recipient macrophages 
remain for at least 365 d (  Fig. 4 C  ). The prolonged survival of 
recipient dermal macrophages is striking. Their median en-
graftment is only 17% at 40 d and 46% at 100 d, with little evi-
dence that GVHD promotes donor engraftment (  Fig. 4 D  ). In 
most samples, there is a slightly greater retention of recipient 
HLA-DR  +  CD14  +   DC than HLA-DR  +  CD14        DC, reaching 
statistical signifi  cance at day 100 (  Fig. 4 C  ). We interpret this 
slight recipient bias as indicating a slightly slower turnover of 
CD14  +   cells and as evidence against their potential role as pre-
cursors of the CD14        (CD1a  +  ) DC. Comparison of the engraft-
ment of dermal DC and LC proves that the majority of 
HLA-DR  +  CD14        dermal DC are not derived from migrating 
LC but have an independent turnover from the blood. Indeed, 
at 40 d, patients transplanted with reduced intensity condition-
ing in the absence of GVHD have a median of 43.1% donor 
LC but 87.7% donor dermal DC (  Fig. 4 D  ). Occasional LC of 
recipient origin were observed among the migrating dermal 
cells but they were consistently   <  2% of HLA-DR  +   cells. 
  Recipient dermal macrophages survive cutaneous GVHD 
  Having demonstrated that recipient dermal macrophages 
are replaced more slowly than either population of dermal 
DC or LC, we sought further evidence that they could survive 
the infl  ammatory insult of GVHD and therefore potentially 
contribute to alloreactivity in the skin. In patients with re-
cent or active acute GVHD, donor DC are found together 
with recipient macrophages. In the example shown (  Fig. 5 A  ), 
there are 92% donor CD14        DC and 90% donor CD14  +   
DC but 83% recipient macrophages.   Eosinophils in the prepa-
ration frequently function as a cytological indicator of active 
    Figure 4.         Posttransplant dermal DC and macrophage chimerism.   
(A) Dual immunofl  uorescence (left) and FISH (right) of migrated dermal cells 
from a female recipient 40 d after transplantation. Donor-derived HLA-
DR  + CD14       DC and HLA-DR  + CD14 +   DC can be seen together with a mixture of 
CD3  +   lymphocytes and a single recipient HLA-DR  +C D14 + FXIIIa +   macrophage. 
A small number of FXIIIa  +   macrophages were seen in migratory preparations 
and, like the one shown, were often recipient in origin but more lightly granu-
lated than the cells released from digested preparations. Bar, 20   μ  m. Dashed 
line indicates stitching of high-power fi  elds. The representative example was 
taken from the cohort of 52 patients. (B) Dual immunofl  uorescence (left) and 
FISH (right) of remnant digested dermal cells from a male recipient 40 d after 
transplantation. Two donor-derived HLA-DR  + CD14       dermal DC can be seen 
together with three recipient HLA-DR  + CD14 + FXIIIa +   macrophages and num-
ber of unlabeled stromal cells. Autofl  uorescent melanin is visible on the FISH 
image of the FXIIIa  +   cells,  confi  rming their identity as macrophages. Bar, 
20   μ  m. Dashed line indicates stitching of high-power fi  elds. The representative 
example was taken from the cohort of 52 patients. (C) Engraftment kinetics 
of dermal DC and macrophages compared with blood myeloid cells, derived 
from a cohort of 52 patients biopsied at 40, 100, and 365 d after transplant. 
Error bars show SD. *, P   <  0.001 compared with any other population (Mann-
Whitney   U   test); **, P = 0.02 comparing CD14  +   DC with CD14        DC  (Wilcoxon 
rank sum test). (D) Engraftment kinetics of each cutaneous APC as a function 
of intensity of conditioning and prior GVHD. GVHD has a signifi  cant effect on 
LC engraftment both at 40 and 100 d but does not infl  uence macrophage 
engraftment. Error bars show SD. *, P   <   0.05 (Mann-Whitney   U   test).   378 DERMAL DC AND MACROPHAGES IN TRANSPLANTATION   | Haniffa et al. 
but at least satisfy the condition that they are present in 
GVHD lesions. 
  Previous studies in mice and humans have shown that 
recipient LC are effi   ciently eliminated by GVHD (  29, 40  ). 
We were surprised to discover that a substantial number of 
recipient macrophages remained even in patients with prior 
GVHD. In the example shown at 1 yr after transplantation 
GVHD. In situ staining of cutaneous GVHD with CD163, 
an alternative macrophage marker, reveals close association be-
tween infi  ltrating T cells and perivascular macrophages (  Fig. 5 B  , 
top left and magnifi  ed bottom inset). Eosinophils are also 
notable in these lesions (  Fig. 5 B  , bottom [asterisks] and in-
set [a and b]). These observations do not prove that recipi-
ent macrophages directly contribute to cutaneous GVHD 
    Figure 5.         Recipient dermal macrophages survive GVHD.   (A) Dual immunofl  uorescence and FISH (insets) of a cytospin of remnant-digested der-
mis from a female patient with acute GVHD 40 d after transplantation. Donor-derived male DC and lymphocytes can be seen in addition to a donor 
eosinophil (arrows). A recipient macrophage is clearly visible. Bar, 20   μ  m. (B) Immunofl  uorescence staining of skin affected by GVHD showing CD163  +  
macrophages in direct contact with infi  ltrating CD3  +   T cells (top left and bottom magnifi  ed inset). Eosinophils appear orange because of their bright 
AF and nonspecifi  c staining (asterisks, a, and b). They are also highly visible in the control with secondary antibodies only (top right) and were con-
fi  rmed in the section at high magnifi  cation (bottom, inset, a and b). Bar, 20   μ  m. The fi  gure shows the results of one of two patients with GVHD ana-
lyzed in the same fashion. (C) Dual immunofl  uorescence and FISH (insets) of a cytospin of digested dermis from a female patient who had prior acute 
GVHD taken at 365 d after transplantation. Recipient macrophages still persist and are highly granulated. Engrafting male donor macrophages by 
comparison are weakly granulated. Bar, 20   μ  m. Dashed lines in insets indicates stitching of high power fi  elds. (D) DNA ploidy analysis of leukocytes 
from normal skin. DAPI histograms are shown from a representative experiment on the left, and the means with cumulative data from fi  ve indepen-
dent experiments are shown on the right. The inset shows a binucleate dermal macrophage from a male patient. Bar, 10   μ  m. *, P   <   0.05 by Mann-
Whitney   U  test compared with neighbor (NS, P = 0.55).     JEM VOL. 206, February 16, 2009 
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Both DC and macrophages exhibit proinfl  ammatory profi  les 
with signifi  cant production of IL-1 and IL-6. This is particu-
larly enhanced by peptidoglycan and poly-IC stimulation, in-
cluding induction of TNF-     and IL-23. Dermal macrophages 
make little IL-10 and do not induce Foxp3  +  CD25  hi   regulatory 
cells from naive T cells in the presence of TGF-     (unpublished 
data). In these experiments, the blood monocyte was notable 
for a very sensitive response to LPS. 
  Allogeneic T cell responses to dermal macrophages 
  The previous results establish that dermal macrophages iso-
lated from normal skin appear to have a proinfl  ammatory 
phenotype. We sought evidence of their potential role in 
antigen-specifi  c alloreactivity by purifying CD1a  +   DC and mac-
rophages from normal dermis and using them to stimulate 
naive CD4  +   T cells, memory CD4  +   T cells, and CD8  +   T 
cells. Proliferative responses, cytokine secretion, and expression 
of activation antigens were measured. As expected, CD1a  +   
dermal DC are     100-fold more potent than macrophages at 
stimulating naive CD4  +   T cells (  Fig. 7 A  ).   Surprisingly, neither 
DC nor macrophages are able to stimulate much proliferation 
in memory CD4  +   T cells, compared with anti-CD3/CD28 
beads, although both cells induce signifi  cant IL-17 and IFN-
     production compared with controls (  Fig. 7 B  ). Macrophages 
are also able to stimulate proliferation, cytokine secretion, 
and expression of activation antigens by allogeneic CD8  +   
T cells. These responses are relatively effi   cient  compared 
with dermal CD1a  +   DC. Macrophages elicit     50% levels of 
proliferation and CD25 expression and similar levels of IFN-
     production and CD69 expression compared with dermal 
and 10 mo after the onset of acute skin GVHD, 32% of mac-
rophages have recipient XX chromosomes (  Fig. 5 C  ). The 
ingestion of melanin appears to increase with the age of the 
cells because recipient cells have a much higher content than 
more juvenile donor cells. 
  To examine mechanisms that promote the survival of 
recipient macrophages, we measured DNA ploidy to deter-
mine their proliferative potential (  Fig. 5 D  ). Both LC and 
CD1a  +   dermal DC contain signifi  cant hyperdiploid fractions, 
2.6 and 1.8% respectively, but CD14  +   DC, macrophages, and 
lymphocytes are all   <  1%. Occasional binucleate, rather than 
G2/M-phase cells, probably account for 0.6% hyperdiploid 
macrophages because there is a virtual absence of any S-phase 
population and binucleate cells were occasionally observed 
on cytospin preparations (  Fig. 5 D  , inset). This observation is 
in keeping with their inability to migrate ex vivo and the no-
tion that macrophages are fi  xed. 
  Dermal macrophages secrete infl  ammatory cytokines 
  The innate immune function of resident dermal macrophages 
has not been previously investigated, and the conventional role 
of macrophages in promoting GVHD by innate mechanisms 
is at odds with more recent descriptions of their regulatory 
role in tissues such as the gut (  49, 50  ). Spontaneous and stimu-
lated cytokine release was measured in comparison with blood 
monocytes ( Fig. 6 ).   Purifi  ed CD1a  +   DC and macrophages were 
obtained by cell sorting freshly digested dermis. Cells were gated 
as outlined in   Fig. 1   and purity after sorting was usually 
at least 95% and viability at least 90% (Fig. S4, available at 
http://www.jem.org/cgi/content/full/jem.20081633/DC1). 
  Figure 6.       Cytokine production by dermal DC and macrophages.   Cytokine analysis in the supernatant from 24-h culture of dermal DC, macro-
phages, and blood monocytes. 40,000 sorted cells were left unstimulated or treated with 10 ng/ml peptidoglycan (PGN), 10   μ  g/ml poly IC, and 0.1   μ  g/ml 
LPS. Data shown are the mean   ±   SEM of at least three independent experiments.     380 DERMAL DC AND MACROPHAGES IN TRANSPLANTATION   | Haniffa et al. 
    Figure 7.         Allostimulatory properties of dermal DC and macrophages.   (A)  [ 3  H]thymidine incorporation of allogeneic CD4  +   T cells stimulated by CD1a  +   DC  or 
macrophages. The left and right show representative examples of six experiments in which APC were titrated against naive and memory T cells as indicated. Stimula-
tion with anti-CD3/28 beads + naive CD4 produced 442   ×   10  3   cpm and with anti-CD3/28 beads + memory CD4 produced 430   ×   10  3   cpm. Results are the mean   ±   SEM 
of triplicate wells. The middle shows the cumulative results and mean of at least seven independent experiments at an APC/T cell ratio of 1:10 compared with medium 
alone controls (T). The stimulation index (SI) was normalized to the proliferation of naive T cells with DC. (B) Intracellular IL-17 and IFN-     production by memory CD4  +   
T cells in response to DC, macrophages, anti-CD3/28 beads, or medium alone. Representative examples of four independent experiments are shown on the left, with 
gating for IL-17  –  expressing Th17 cells and IFN-      –  expressing Th1 cells. The mean and cumulative results of four independent experiments are shown on the right, 
expressed as the percentage of Th17, Th17/1, or Th1 cells in each. (C) [  3  H]thymidine incorporation of allogeneic CD8  +   T cells stimulated by dermal DC or macrophages 
or medium alone (T). The left shows a representative example of the data at an APC/T cell ratio of 1:10. Results are the mean   ±   SEM of triplicate wells. The right shows 
the cumulative results and mean of six independent experiments. (D) IFN-     secretion into the medium of CD8  +   T cells stimulated with DC, macrophages, medium 
alone (T), or anti-CD3/CD28 beads (beads). Results show the mean   ±   SEM of six independent experiments. (E) Activation antigen expression by CD8  +   T cells stimulated 
by DC, macrophages, anti-CD3/28 beads, or medium alone. Representative examples of the data with gating for positive cells are shown on the left. The mean and 
cumulative results of four independent experiments are shown on the right, expressed as the percentage of positive cells in each.    JEM VOL. 206, February 16, 2009 
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DC (  Fig. 7, C  –  E  ). These results confi  rm the classical view of 
macrophages as poor stimulators of naive T cells. They also 
highlight a recent and unexpected fi  nding that tissue-derived 
myeloid DC may be much less effi   cient at stimulating mem-
ory T cell proliferation than previously assumed (  51  ). Finally, 
the ability of macrophages to induce cytokine responses in 
memory CD4  +   T cells and stimulate CD8  +   T cells suggests 
that they could potentiate the responses of alloreactive T cells 
during transplantation. 
    DISCUSSION   
  Elucidation of the ontogeny and function of myeloid APC is 
critical to understanding the generation of immunity. More-
over, the initiation of graft versus host responses in hematopoi-
etic stem cell transplantation is governed by the persistence of 
recipient APC of undefi  ned origin and location. To under-
stand this problem further, we set out to solve the complexity 
of human interstitial APC, characterize their survival after he-
matopoietic stem cell transplantation, and assess their innate 
and antigen-specifi  c interactions with allogeneic T cells. 
  We have presented a comprehensive analysis of der-
mal APC that allows us to understand not only previous data 
using dual immunofl   uorescence to study DC and mac-
rophages in situ (  9, 10  ) but also more functional stud-
ies that have focused on the isolation of diff  erent  skin 
migratory DC populations (  11, 14  –  20  ). We fi  nd  three 
principal subsets of myeloid cells in human dermis: HLA-
DR  +  CD14       CD1a  +   DC; HLA-DR  +  CD14  +  CD1a        DC and 
HLA-DR  +  CD14  +  CD1a       FXIIIa  +   dermal macrophages. The 
CD14  +   DC migrates in vitro but retains some intermediate 
properties of both DC and macrophages. As a migratory cell, 
recent evidence indicates that it has a specialized function in 
priming follicular helper CD4  +   T cells (  20  ). Most previous 
reports have not fully accounted for the existence of three 
distinct populations. Studies on migratory cells containing 
CD1a  +   and CD14  +   DC are unable to determine the origin of 
these cells in situ because they do not account for the major 
population of macrophages, which share a number of mark-
ers with CD14  +   DC but do not migrate. In situ studies have 
focused on two populations, CD1a  +   DC and macrophages, 
but do not defi  ne the place of the CD14  +   DC (  9, 10  ). Others, 
using freshly digested dermis, have not explicitly excluded 
macrophages from the CD14  +   DC subset. This potentially 
distorts the characterization of freshly isolated CD14  +   DC 
and makes them appear more like macrophages when they 
are compared with CD1a  +   DC (  11, 16, 18  ). 
  Human dermal macrophages can be distinguished by SSC 
and AF and constitute up to 40% of CD45  +  HLA-DR  +   der-
mal cells. Their characteristic physical properties are a result 
of the ingestion of huge quantities of melanin. Tattoo pig-
ment ingestion by dermal macrophages was recently high-
lighted (  9  ), but our data suggests that melanin uptake is a 
signifi  cant physiological function in normal skin. Indeed the 
term   “  melanophage,  ”   which is usually reserved for describing 
phagocytes seen in hyperpigmentation disorders or melanotic 
lesions (  52  –  55  ), is entirely appropriate. Macrophages are marked 
by CD14, CD163, and FXIIIa as previously noted (  9, 56, 57  ). 
We demonstrated the specifi  city of FXIIIa staining on cyto-
spins by showing that it colocalizes with large cells containing 
melanosomes. A similar pattern of staining is observed in vi-
tro. Flow cytometry reveals low level expression of FXIIIa by 
DC as previously reported (  9, 14, 20  ), but the level is ap-
proximately tenfold lower than on macrophages. 
  Low SSC, nonautofl  uorescent CD45  +  HLA-DR  +   cells of 
the dermis contain the two migratory APC of the dermis 
characterized by the expression of CD1a and CD14, respec-
tively. Previous comparisons of skin migratory or in vitro  –
  derived CD1a  +   and CD14  +   cells have concluded that the 
CD14  +   is a form of immature or specialized DC (  18, 19, 58, 59  ). 
The most recent of these analyses shows that migratory 
CD14  +   DC have a specifi  c function in priming follicular helper 
T cells (  20  ). Others have suggested additionally that a com-
ponent of these cells can diff  erentiate into LC (  16  ) or macro-
phages (  11  ). Because the CD14  +   DC has slightly delayed 
engraftment relative to the CD1a  +   cell, it cannot be an im-
mediate precursor of CD1a  +   DC. Indeed, its phagocytic prop-
erties, lack of DNA synthesis, and morphology are reminiscent 
of dermal macrophages. It could be argued that the CD14  +   
cells, or at least a subset of them, are precursors of macro-
phages that have just not yet acquired a niche in the dermis. 
Further studies will be required to clarify that these cells actu-
ally traffi   c to the LN. Certainly, in vitro studies suggest a 
much inferior migratory capacity in response to CCR7 li-
gands (  18  ). Although it is conceivable that circulating mono-
cytes might be included among the dermal CD14  +   population, 
we found little evidence to support this. 
  Having defi  ned the myeloid cells of human dermis in 
detail, we examined their replacement during hematopoietic 
stem cell transplantation. After conditioning therapy, CD1a  +   
dermal DC are rapidly depleted, whereas CD14  +   DC and macro-
phages are retained. After transplantation, both dermal DC 
are replaced by cells from the donor within weeks, but mac-
rophages remain at least partly of recipient origin for   >  1 yr. 
This result supports the view that resident macrophages and 
immature DC are two distinct lineages at the tissue level, 
even though they share some markers and physiological attri-
butes and are ultimately both BM derived. It is unlikely that 
resident macrophages are able to mature into migratory 
myeloid DC but more conceivable that they retain a distinct 
functional role in the dermis, even during infl  ammation. 
Their survival is consistent with our previous observation 
that a fraction of human HLA-DR  +   dermal cells remain 
recipient in origin for at least 1 mo after transplantation (  47  ). 
Prior reports of human alveolar macrophages and Kupff  er cells 
have emphasized their BM origin and described complete donor 
engraftment within 3 mo (  24, 25  ). Neither alveolar macro-
phages nor Kupff  er cells may be typical of interstitial macro-
phages resident within epithelia such as the skin and gut. 
Unlike recipient LC, which turn over in response to infl  am-
mation, recipient macrophages survive GVHD and can be 
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  Overall, it is unlikely that recipient macrophages are suffi   -
cient to induce acute GVHD, but their ability to stimulate cyto-
kine production by memory CD4  +   T cells and to activate 
CD8  +   T cells is consistent with a role in which they may 
potentiate allogeneic responses locally. Clinically, this could 
contribute to relapses of acute GVHD mediated by antigen-
experienced T cells after immunosuppression withdrawal in 
the manner of a secondary viral infection (  68  ). Immunosup-
pression is frequently maintained until 3 mo after transplanta-
tion in humans, long after the replacement of DC and LC, but 
not macrophages, by donor cells. In addition, there are clear 
threshold eff  ects to GVHD induction by DLI in humans (  34  –
  38  ), and persistent recipient macrophages could promote post-
DLI GVHD by raising the frequency of alloreactive T cells 
above a critical level. Recipient macrophages in a number of 
sites might also contribute to chronic GVHD, and provide a 
source of recipient hematopoietic minor histocompatibility 
antigen, to stimulate graft versus leukemia responses. 
  In conclusion, this study provides a comprehensive descrip-
tion and functional analysis of human dermal APC, with suffi   -
cient resolution to demonstrate the diff  erences in replacement 
of DC and macrophages after hematopoietic stem cell trans-
plantation. We fi  nd evidence that dermal DC and macrophages 
are independent lineages and that surviving macrophages may 
have the potential to sustain graft versus host responses long 
after recipient DC have been eliminated. 
  MATERIALS AND METHODS 
  Cell isolation and culture.     Human samples were obtained after informed 
consent and ethical permission from the Newcastle Research Ethics Com-
mittee. Normal skin was obtained from mammoplasty surgery, and 2  –  4-mm 
shave skin biopsies were taken from the posterior iliac crest of patients un-
dergoing transplantation. Epidermal and dermal sheets were prepared by di-
gestion of patient shave biopsies or 300-  μ  m skin dermatome sections of 
normal skin with 1 mg/ml dispase (Invitrogen) in RPMI (Invitrogen) for 
60 min at 37  °  C. Large dermal sheets were cut into 0.5-cm squares or smaller 
and incubated with 0.8 mg/ml collagenase (Type IV; Worthington) in 
RPMI with 10% FCS for 8 h in a bacterial Petri dish to prevent adherence 
of leukocytes or cultured in RPMI (or X-Vivo 10; Cambrex) with 500 U/ml 
GM-CSF (Sargramostim; Durbin PLC) for collection of migrating cells. 
After 72 h of migration, dermal remnants were treated with collagenase in 
the same manner as fresh dermis. Viability was usually 80  –  90% by DAPI ex-
clusion (Partec). Dermal macrophages and DC were isolated to   >  95% purity 
from freshly digested dermal cells suspension by fl  uorescence activated cell 
sorting using a FACS Aria Special Order System (BD) confi  gured with 100-mW 
488-nm sapphire lasers, 60-mW 350-nm UV lasers, 40-mW 640-nm red la-
sers, 50-mW 407-nm violet lasers, a 100-  μ  m nozzle, and 20 psi (Fig. S4). 
Macrophage AF was detected using the 488-nm excitation laser with a band-
pass fi  lter of 530/30 nm. 
  Naive and memory CD4  +   T cells were isolated to   >  90% purity by auto-
mated magnetic negative selection using EasySep human naive and memory 
CD4  +   T cell isolation kits and RoboSep (StemCell Technologies Inc.) from 
peripheral blood mononuclear cells. CD8  +   T cells were isolated to   >  95% 
purity by negative selection using RosetteSep CD8  +   T cell isolation cocktail 
from whole blood (StemCell Technologies Inc.). Monocyte-derived DC were 
generated from magnetically isolated CD14  +   monocytes (Miltenyi Biotec) and 
cultured for 6 d with 50 ng/ml GM-CSF and IL-4 (R  &  D Systems), followed 
by 24-h activation with 0.1   μ  g/ml LPS (Sigma-Aldrich), 10 ng/ml IL-1     
(PeproTech), and 10 ng/ml TNF-     (PeproTech). 
with T cells. They are progressively replaced by donor cells 
but with relatively invariant kinetics. There are also marked 
diff  erences in the turnover of epidermal LC compared with 
dermal DC, which is most easily seen after reduced intensity 
conditioning. This reinforces the idea that LC have self-re-
newal capacity in humans. 
  The importance of the innate response of recipient mac-
rophages to the induction of GVHD is well accepted (  31, 32, 
60  ). However, direct observations on human macrophages 
are scarce. Moreover, recent studies in the gut have assigned 
an antiinfl  ammatory role to tissue macrophages through the 
production of IL-10 and fostering of regulatory T cell devel-
opment (  49, 50  ). Our results show, in contrast, that dermal 
macrophages are natural producers of IL-1 and IL-6 and syn-
thesize TNF-     and IL-23 upon stimulation. Compared with 
monocytes, dermal macrophages are more polarized to re-
spond to peptidoglycan and poly IC than to LPS, presumably 
refl  ecting the range of gram positive and viral pathogens they 
are likely to encounter in the skin. 
  We argue that in addition to providing critical infl  amma-
tory signals, recipient macrophages may also have the capacity to 
enhance GVHD through antigen-specifi  c means by present-
ing host tissue antigens. This concept has precedence in mouse 
data showing that macrophages can play a primary role in the 
induction of antigen-specifi  c cellular immunity (  61  ) and alloge-
neic responses (  62  ). Experiments using clodronate liposome-
treated mice also suggest a role for local resident macrophages 
in recruiting and targeting T cells to sites of GVHD (  30  ). 
  Testing the function of human APC in alloreactivity is 
complex because it is not immediately apparent in humans 
whether CD4  +   or CD8  +   T cells or both must be activated to 
induce GVHD or whether naive or memory T cell subsets 
contain the critical alloreactive populations. Lymphocyte re-
circulation must also be considered. Memory CD4  +   T cells 
form the bulk of dermal T cells in normal skin (  63, 64  ), and 
it is therefore unlikely that nonmigratory macrophages come 
into contact with naive CD4  +   T cells, at least under quiescent 
conditions. However, a direct interaction with CD8  +   T cells 
is possible because we have consistently observed CD8  +   T 
cells in the dermis of transplant patients, even in the absence 
of clinical GVHD (unpublished data). 
  We were initially surprised to fi  nd that there was almost no 
proliferative response of memory CD4  +   T cells to allogeneic 
DC or macrophages, given that memory cells are known to 
have a lower threshold for proliferation when stimulated via 
CD3/CD28 ligation (  65  ). However, recent in vivo data show 
that migratory myeloid DC are very ineffi   cient at stimulating 
the proliferation of CD8  +   memory cells (  51  ). The mechanism 
of this remains unknown and there are no previous studies in 
humans testing the proliferative response of memory CD4  +   T 
cells to primary tissue DC. Recent work using in vitro  –  derived 
DC shows stimulation of memory CD4  +   cell cytokine re-
sponses, which is consistent with our fi  ndings (  20  ). An addi-
tional possibility that we cannot exclude is that the CD4  +   
memory T cell population in humans may not contain allore-
active cells, as has been described in mouse systems (  66, 67  ). JEM VOL. 206, February 16, 2009 
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  Proliferation and T cell cytokine production assays.     10  4   fl  ow-sorted 
dermal macrophages or DC were cultured with 10  5   allogeneic naive CD4  +  , 
memory CD4  +  , or CD8  +   T cells in round-bottomed 96-well plates. CD3/28 
beads were used at 1:1 ratio. On day 5 of alloreaction, the cultures received 
a 16-h pulse of 0.548 Mbq/ml [  3  H]thymidine (TRA310; GE Healthcare). 
Thymidine incorporation was measured using a luminescence counter (Micro-
Beta TriLux; PerkinElmer). CD25 and CD69 expression on CD8  +   T cells were 
analyzed on day 5 of alloreactions. Supernatant from CD8  +   alloreactions 
were collected on day 5 for IFN-     analysis using cytometric bead array 
(BD). On day 6 of alloreactions, memory CD4  +   T cells were stimulated with 
50 ng/ml PMA (Sigma-Aldrich) and 500 ng/ml ionomycin (Sigma-Aldrich) 
for 5 h in the presence of 10   μ  g/ml brefeldin A (Sigma-Aldrich) for the last 
4 h before intracellular staining for IFN-     and IL-17. 
  Statistical analyses.     Mann-Whitney   U   and Wilcoxon Rank Sum tests 
were performed using Prism 4.0 (GraphPad Software, Inc.). All p-values are 
two tailed. 
  Online supplemental material.     Fig. S1 A shows the expression of FXIIIa in 
situ by immunofl  uorescence and correlates this with macrophages containing 
intracellular melanosomes. Fig. S1 B shows the relative messenger RNA ex-
pression of FXIIIa in CD1a  +   DC, CD14  +   DC, and macrophages. Fig. S2 gives 
additional examples of cytospin preparations used to determine posttransplant 
engraftment of APC and Fig. S3 shows that similar results are obtained using 
freshly digested, migrated, or remnant digest preparations. Fig. S4 shows purity 
after sorting of CD1a  +   DC and macrophages used in the functional studies of 
the paper. Table S1 describes patients analyzed before and after conditioning 
therapy. Table S2 shows patients analyzed for dermal APC chimerism. Table S3 
presents the raw data used for chimerism analysis. Online supplemental material 
is available at http://www.jem.org/cgi/content/full/jem.20081633/DC1. 
  We thank the patients, Stem Cell Transplant team, and Department of Plastic and 
Reconstructive Surgery at the Royal Victoria Infi  rmary, Newcastle upon Tyne. We 
also gratefully acknowledge the advice of Nick Bown and Wing-Hong Kwan and 
helpful discussion of Gwen Randolph, Milena Bogunovic, and Julie Helft. 
  This work was funded by the Leukaemia Research Fund (UK), Action Medical 
Research, Histiocytosis Association of America, Tyneside Leukaemia Research 
Association, and Newcastle Healthcare Charity. 
  The authors have no confl  icting fi  nancial interests. 
Submitted:   25 July 2008 
Accepted:   18 December 2008 
  REFERENCES 
       1  .   Steinman  ,   R.M.  ,   D.S.     Lustig  , and   Z.A.     Cohn  .   1974  .   Identifi  cation of a 
novel cell type in peripheral lymphoid organs of mice. III. Functional 
properties in vivo.       J. Exp. Med.       139  :  1431    –    1445  .    
       2  .   Ueno  ,   H.  ,   E.     Klechevsky  ,   R.     Morita  ,   C.     Aspord  ,   T.     Cao  ,   T.     Matsui  , 
  T.     Di Pucchio  ,   J.     Connolly  ,   J.W.     Fay  ,   V.     Pascual  ,   et al  .   2007  .   Dendritic 
cell subsets in health and disease.       Immunol. Rev.       219  :  118    –    142  .    
       3  .   Lee  ,   S.H.  ,   P.M.     Starkey  , and   S.     Gordon  .   1985  .   Quantitative analysis 
of total macrophage content in adult mouse tissues. Immuno-
chemical studies with monoclonal antibody F4/80.       J. Exp. Med.     
  161  :  475    –    489  .    
       4  .   Gordon  ,   S.  , and   P.R.     Taylor  .   2005  .   Monocyte and macrophage hetero-
geneity.       Nat. Rev. Immunol.       5  :  953    –    964  .    
       5  .   Steinman  ,   R.  ,   L.     Hoff  man  , and   M.     Pope  .   1995  .   Maturation and migra-
tion of cutaneous dendritic cells.       J. Invest. Dermatol.       105  :  2S    –    7S  .    
       6  .   Kissenpfennig  ,   A.  ,   S.     Henri  ,   B.     Dubois  ,   C.     Laplace-Builhe  ,   P.     Perrin  , 
  N.     Romani  ,   C.H.     Tripp  ,   P.     Douillard  ,   L.     Leserman  ,   D.     Kaiserlian  , 
  et al  .   2005  .   Dynamics and function of Langerhans cells in vivo: dermal 
dendritic cells colonize lymph node areas distinct from slower migrating 
Langerhans cells.       Immunity      .     22  :  643    –    654  .    
       7  .   Ginhoux  ,   F.  ,   M.P.     Collin  ,   M.     Bogunovic  ,   M.     Abel  ,   M.     Leboeuf  ,   J.   
  Helft  ,   J.     Ochando  ,   A.     Kissenpfennig  ,   B.     Malissen  ,   M.     Grisotto  ,   et al  . 
  2007  .   Blood-derived dermal langerin  +   dendritic cells survey the skin in 
the steady state.       J. Exp. Med.       204  :  3133    –    3146  .    
  Flow cytometry.     Flow cytometry was performed with LSRII and FACS-
Calibur cytometers (BD) and data was analyzed with FlowJo (Tree Star, 
Inc.). Intracellular staining was performed after fi  xation and permeabilization 
with Cytofi  x/Cytoperm and Perm/Wash reagents (BD). 70,000 MW FITC 
coated-dextran particles were obtained from Sigma-Aldrich. For determina-
tion of DNA ploidy, cells were surfaced stained, washed, and fi  xed with 
0.5% paraformaldehyde for 5 min. This was followed by a subsequent wash, 
further fi  xation with 50% cold ethanol for 30 min, and a fi  nal wash before 
resuspending in 2   μ  g/ml DAPI solution. The following antibodies were sup-
plied by BD unless stated otherwise and are denoted as antigen fl  uorochrome 
(clone): CD1a FITC (NA1/34; Dako); CD1a APC (HI 149); CD1c APC 
(AD5-8E7; Miltenyi Biotec); CD3 PE (SK7); CD11b PE (ICRF 44); CD11c 
APC (B-ly6); CD14 PE and PECy7 (M5E2); CD45 APC Cy7 (2D1); CD80 
PE (L307.4); CD83 APC (HB15); CD86 APC (2331:FUN-1); CD163 APC 
(215927; R  &  D Systems); HLA-DR FITC, APC, and PerCP Cy5.5 (L243); 
CCR7 APC (150503; R  &  D Systems); IL-17A Alexa Fluor 647 (eBio-
64DEC17; eBioscience); IFN-     FITC (25723.11); FXIIIa (sheep polyclonal; 
Enzyme Research Laboratories) with APC-conjugated donkey anti  –  sheep 
(Invitrogen); CD52 PE (YTH34.5; AbD Serotec). 
  Microscopy.     Laser confocal microscopy was performed using a confocal 
microscope (TCS SP2; Leica). Fluorescence microscopy was performed us-
ing a microscope (Axioplan 2; Carl Zeiss, Inc.). The following antibodies 
were used to stain paraffi     n-embedded sections: HLA-DR (L243; BD); 
FXIIIa (sheep polyclonal; Enzyme Research Laboratories); CD3 (rabbit 
polyclonal; Abcam); CD163 (NCL-CD163; Leica). The following second-
ary detection reagents were supplied by Invitrogen: Alexa Fluor 555  –  conju-
gated goat anti  –  rabbit, Alexa Fluor 568  –  conjugated goat anti  –  mouse, Alexa 
Fluor 633  –  conjugated donkey anti  –  sheep, and Alexa Fluor 633  –  conjugated 
goat anti  –  mouse. 
  Enumeration of dermal DC and macrophages.     Shave biopsies were 
cut with a 2-mm punch and digested with dispase to separate the epidermis 
and obtain a 3.14-mm  2   disk of dermis. This was further digested with 0.8 
mg/ml of collagenase for 12 h and dispersed to obtain a single cell suspen-
sion. Cells were washed once, stained with antibodies to CD45, HLA-DR, 
CD14, and CD1a, washed again, and transferred to 400   μ  l of buff  er in a 
Trucount tube (BD). 30,000  –  50,000 events were recorded. Reproducibility 
of biopsy procedure and cell preparation was monitored by recording the 
weight and the fi  broblast content. 
  Chimerism analysis.     Dermal cells prepared from clinical biopsies were harvested 
by spinning onto cytospin slides at 800 rpm for 5 min using a cytocentrifuge (Shan-
don Cytospin 4; Thermo Fisher Scientifi  c). Cytospin slides were air dried and 
stored at     20  °  C before sequential immunofl  uorescence and FISH. Slides were 
thawed and fi  xed in methanol then stained with antibodies to CD14 (rabbit poly-
clonal; Abcam), CD3 (SK7; BD), and FXIIIa (AC-1A1; Abcam) combined with 
secondary Alexa Fluor 555  –  conjugated goat anti  –  rabbit and Alexa Fluor 633  –  con-
jugated goat anti  –  mouse IgG1 (Invitrogen) and directly conjugated anti  –  HLA-
DR FITC. 10  –  12   ×   40 four-color images were acquired by confocal microscopy 
and assembled into montages using Photoshop CS2 (Adobe). Cytospin slides were 
then fi  xed with methanol/acetic acid 3:1 for 5 min, probed with CEP X/Y DNA 
probes (Vysis; Abbott Molecular), mounted with Vectastain containing DAPI 
(Vector Laboratories), and scored for X/Y hybridization. Migratory LC were pro-
cessed in a similar manner as previously described (  40  ). Together, a total of 18,370 
interphase nuclei were examined in 149 samples taken from 52 patients. 
  Dermal APC stimulation with TLR ligands.     4   ×   10  4   fl  ow-sorted der-
mal macrophages or DC were cultured in 96-well fl  at-bottomed plates. Su-
pernatant from unstimulated and cells stimulated with 0.1   μ  g/ml LPS 
(Sigma-Aldrich), 10 ng/ml peptidoglycan (InvivoGen), and 10   μ  g/ml poly 
I:C (InvivoGen) were collected after 24 h of culture for cytokine analysis. 
TNF-    , IL-1, IL-6, IL-10, and IL-12p70 were detected using cytometric 
bead arrays (CBA-Flex; BD) and analyzed with Array software v1.0 (BD), 
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